These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15380632)

  • 41. Dissolution-modulating mechanism of alkalizers and polymers in a nanoemulsifying solid dispersion containing ionizable and poorly water-soluble drug.
    Tran TT; Tran PH; Lee BJ
    Eur J Pharm Biopharm; 2009 May; 72(1):83-90. PubMed ID: 19141319
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Water-in-oil microemulsions containing medium-chain fatty acids/salts: formulation and intestinal absorption enhancement evaluation.
    Constantinides PP; Welzel G; Ellens H; Smith PL; Sturgis S; Yiv SH; Owen AB
    Pharm Res; 1996 Feb; 13(2):210-5. PubMed ID: 8932438
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Formulation of a drug delivery system based on a mixture of monoglycerides and triglycerides for use in the treatment of periodontal disease.
    Norling T; Lading P; Engström S; Larsson K; Krog N; Nissen SS
    J Clin Periodontol; 1992 Oct; 19(9 Pt 2):687-92. PubMed ID: 1447387
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In-vitro evaluation of khaya and albizia gums as compression coatings for drug targeting to the colon.
    Odeku OA; Fell JT
    J Pharm Pharmacol; 2005 Feb; 57(2):163-8. PubMed ID: 15720778
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enzymatic synthesis of monolaurin.
    Pereira CC; da Silva MA; Langone MA
    Appl Biochem Biotechnol; 2004; 113-116():433-45. PubMed ID: 15054269
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
    Yi T; Wan J; Xu H; Yang X
    Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biodegradable in situ gelling system for subcutaneous administration of ellagic acid and ellagic acid loaded nanoparticles: evaluation of their antioxidant potential against cyclosporine induced nephrotoxicity in rats.
    Sharma G; Italia JL; Sonaje K; Tikoo K; Ravi Kumar MN
    J Control Release; 2007 Mar; 118(1):27-37. PubMed ID: 17258836
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stimuli responsive liquid crystals provide 'on-demand' drug delivery in vitro and in vivo.
    Fong WK; Hanley T; Boyd BJ
    J Control Release; 2009 May; 135(3):218-26. PubMed ID: 19331865
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Physicochemical characterization and evaluation of a microemulsion system for antimicrobial activity of glycerol monolaurate.
    Fu X; Feng F; Huang B
    Int J Pharm; 2006 Sep; 321(1-2):171-5. PubMed ID: 16797893
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ternary cubic phases containing ionic liquid.
    Wang Z; Zhou W; Li G
    J Colloid Interface Sci; 2008 Feb; 318(2):405-10. PubMed ID: 17996884
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of a high-throughput in vitro intestinal lipolysis model for rapid screening of lipid-based drug delivery systems.
    Mosgaard MD; Sassene P; Mu H; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2015 Aug; 94():493-500. PubMed ID: 26159837
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel pH-dependent gradient-release delivery system for nitrendipine II. Investigations of the factors affecting the release behaviors of the system.
    Yang M; Cui F; You B; Wang L; Yue P; Kawashima Y
    Int J Pharm; 2004 Nov; 286(1-2):99-109. PubMed ID: 15501006
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The potential for drug supersaturation during intestinal processing of lipid-based formulations may be enhanced for basic drugs.
    Yeap YY; Trevaskis NL; Porter CJ
    Mol Pharm; 2013 Jul; 10(7):2601-15. PubMed ID: 23697606
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aqueous phase behavior of a 1-O-phytanyl-beta-D-xyloside/water system. Glycolipid-based bicontinuous cubic phases of crystallographic space groups Pn3m and Ia3d.
    Hato M; Yamashita I; Kato T; Abe Y
    Langmuir; 2004 Dec; 20(26):11366-73. PubMed ID: 15595758
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhancing the bioavailability of ABT-963 using solid dispersion containing Pluronic F-68.
    Chen Y; Zhang GG; Neilly J; Marsh K; Mawhinney D; Sanzgiri YD
    Int J Pharm; 2004 Nov; 286(1-2):69-80. PubMed ID: 15501003
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aqueous-phase behavior of natural glycolipid biosurfactant mannosylerythritol lipid A: sponge, cubic, and lamellar phases.
    Imura T; Hikosaka Y; Worakitkanchanakul W; Sakai H; Abe M; Konishi M; Minamikawa H; Kitamoto D
    Langmuir; 2007 Feb; 23(4):1659-63. PubMed ID: 17279642
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers.
    Ahuja N; Katare OP; Singh B
    Eur J Pharm Biopharm; 2007 Jan; 65(1):26-38. PubMed ID: 16962750
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Understanding a relaxation behavior in a nanoparticle suspension for drug delivery applications.
    Deng Z; Xu S; Li S
    Int J Pharm; 2008 Mar; 351(1-2):236-43. PubMed ID: 18093763
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development and in-vivo evaluation of insulin-loaded chitosan phthalate microspheres for oral delivery.
    Ubaidulla U; Khar RK; Ahmed FJ; Panda AK
    J Pharm Pharmacol; 2007 Oct; 59(10):1345-51. PubMed ID: 17910808
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structural and rheological investigation of Fd3m inverse micellar cubic phases.
    Pouzot M; Mezzenga R; Leser M; Sagalowicz L; Guillot S; Glatter O
    Langmuir; 2007 Sep; 23(19):9618-28. PubMed ID: 17696371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.